Sorrento Therapeutics Inc (SRNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRNE | AMGN | BMY | GILD | VRTX |
| Company | Sorrento Therapeutics Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.0275 | 267.54 | 48.00 | 67.03 | 394.94 |
| High | 0.0400 | 268.77 | 48.00 | 67.03 | 398.11 |
| Low | 0.0220 | 263.39 | 48.00 | 67.03 | 392.03 |
| Last | 0.0280 | 264.07 | 48.00 | 67.03 | 393.10 |
| Change | +0.0005 | -1.57 | +0.16 | +0.10 | -1.07 |
| % Change | +1.82% | -0.59% | +0.33% | +0.15% | -0.27% |
| Volume | 42,400 | 2,175,100 | 5,933 | 915 | 881,000 |
| 20-Day Average Volume | 286,530 | 2,225,995 | 10,873,977 | 5,892,846 | 901,850 |
| Previous Close | 0.0275 | 265.64 | 47.84 | 66.93 | 394.17 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0176 | 273.48 | 50.97 | 70.26 | 407.52 |
| 20-Day Raw Stochastic | 30.56% | 2.72% | 4.43% | 1.89% | 3.63% |
| 20-Day Relative Strength | 51.89% | 37.63% | 35.67% | 30.28% | 36.51% |
| Weighted Alpha | -91.76 | +4.99 | -30.76 | -23.89 | +15.47 |
| Today's Opinion | 56% Sell | 56% Sell | 72% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 56% Sell | 40% Sell | 56% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 100% Sell | 8% Sell | 24% Sell | 88% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -15.15% since 04/10/24 | -0.89% since 04/10/24 | -2.28% since 04/11/24 | -2.36% since 04/11/24 | -1.13% since 04/10/24 |
| Low | 0.0032 on 04/11/24 | 263.39 on 04/17/24 | 47.70 on 04/17/24 | 66.89 on 04/17/24 | 392.03 on 04/17/24 |
| High | 0.0848 on 04/15/24 | 273.00 on 04/11/24 | 49.10 on 04/15/24 | 68.62 on 04/12/24 | 404.69 on 04/11/24 |
| 1-Month | |||||
| %Chg | +55.56% since 03/15/24 | -1.79% since 03/15/24 | -6.96% since 03/18/24 | -8.50% since 03/18/24 | -3.58% since 03/15/24 |
| Low | 0.0030 on 04/04/24 | 263.39 on 04/17/24 | 47.70 on 04/17/24 | 66.89 on 04/17/24 | 392.03 on 04/17/24 |
| High | 0.0848 on 04/15/24 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -72.55% since 01/17/24 | -13.16% since 01/17/24 | -4.17% since 01/18/24 | -22.42% since 01/18/24 | -9.37% since 01/17/24 |
| Low | 0.0010 on 01/30/24 | 263.39 on 04/17/24 | 47.58 on 02/06/24 | 66.89 on 04/17/24 | 392.03 on 04/17/24 |
| High | 0.1090 on 01/18/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -73.53% since 10/17/23 | -7.15% since 10/17/23 | -15.57% since 10/18/23 | -15.87% since 10/18/23 | +5.25% since 10/17/23 |
| Low | 0.0010 on 01/30/24 | 249.70 on 10/31/23 | 47.58 on 02/06/24 | 66.89 on 04/17/24 | 341.90 on 11/16/23 |
| High | 0.2495 on 12/22/23 | 329.72 on 02/05/24 | 57.09 on 10/20/23 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 15,436 | 141,520,144 | 96,960,152 | 83,333,008 | 101,600,240 |
| Shares Outstanding, K | 551,281 | 535,919 | 2,026,759 | 1,245,077 | 258,459 |
| Annual Sales | 52,900,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -428,330,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 17,400,000 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -89,576,000 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 2.25 | 0.58 | 0.39 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.17 on 08/11/23 | 4.71 on 02/06/24 | 1.70 on 02/02/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/20/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.24 | 6.43 | 10.02 | 29.33 |